illinois science + technology park

01/29/2026

2026 Illinois Rare Disease Day in Springfield
March 24, 2026 - March 25, 2026
https://ibio.app.neoncrm.com/nx/portal/neonevents/events?

01/29/2026

The AbbVie Foundation Is Now Accepting Applications to Participate in the 2026 AbbVie Foundation Health Equity Accelerator
https://www.businesswire.com/news/home/20260127760699/en/The-AbbVie-Foundation-Is-Now-Accepting-Applications-to-Participate-in-the-2026-AbbVie-Foundation-Health-Equity-Accelerator?

The AbbVie Foundation, a 501(c)(3) nonprofit working to drive transformative change and advance health equity in communities worldwide, in partnership with M...

01/28/2026

Liquidity in US VC showed meaningful signs of improvement in 2025, driven by a handful of high-profile IPOs that delivered much-needed exits and renewed confidence in public markets
https://pitchbook.com/news/reports/q1-2026-pitchbook-analyst-note-2026-ipo-outlook-for-us-vc?

This analyst note examines how policy alignment, valuation resets, and uneven post-IPO performance are shaping a gradual and uncertain recovery for the US IPO market heading into 2026.

01/28/2026

That 2025 was a record year is beyond dispute
https://pitchbook.com/news/articles/the-secondary-markets-capitalization-conundrum?

Secondaries funds continue to raise record amounts, but not enough to meet the potential supply of deals

01/28/2026

The Winter Market on Main is back — and it’s twice as big as last year. This indoor and outdoor market is open Sundays from January through April, 8:30 a.m. to 12:30 p.m.

Skokie's famous, fabulous, fantastic Farmers' Market, celebrating more than a quarter century of operation, presents farmers and vendors from Illinois, Indiana, Michigan and Wisconsin.

01/28/2026

Illinois attracted a range of projects that reflect its building momentum as a business powerhouse
https://dceo.illinois.gov/content/dam/soi/en/web/dceo/documents/ilinois-2024-economic-growth-plan.pdf?

01/28/2026

Illinois offers unparalleled multimodal transportation infrastructure, connecting companies to markets worldwide by air, rail, road, and port
https://www.illinoisedc.org/news/air-rail-road-port-why-global-supply-chains-run-through-illinois/?

Across nearly every industry, one thing is constant: the need for fast, reliable, and efficient transportation, distribution, and logistics. And no state in the U.S. nor location in the world moves business better than Illinois.

01/27/2026

As 2026 begins, optimism is cautiously returning
https://pitchbook.com/news/reports/q4-2025-pitchbook-nvca-venture-monitor?

The Q4 2025 PitchBook-NVCA Venture Monitor presents a data-driven overview of the key trends defining the US venture capital landscape.

01/27/2026

About the BIO Investment & Growth Summit

The BIO Investment & Growth Summit is where biotechnology CEOs, investors, and thought leaders come together for BIO Partnering meetings, networking, and timely content.

01/27/2026

It’s where we see depth of capital markets and the quality investors
https://www.fiercebiotech.com/biotech/things-are-looking-are-british-biotechs-considering-ipos-after-years-long-drought?

Despite remaining a fertile hunting ground for Big Pharmas to snap up biotechs or license new therapies, the U.K. | Despite remaining a fertile hunting ground for Big Pharmas to snap up biotechs or license new therapies, the U.K. hasn’t produced any new publicly listed drug developers of its own f...

01/26/2026

Please explore the AV 100 list of remarkable ventures across sectors ranging from next-gen energy power and quantum computing to AI-driven drug discovery, space logistics, brain-computer interfaces, blockchain infrastructure, defense tech, and beyond.
https://www.av.vc/blog/av100?

Discover Alumni Ventures’ AV 100 2026 — 100 standout portfolio companies selected for innovation, performance, and strong future growth potential.

01/26/2026

China’s biopharma sector is entering 2026 with renewed momentum
https://pitchbook.com/news/reports/q1-2026-pitchbook-analyst-note-the-chinese-biopharma-landscape-where-new-assets-are-born?

This analyst note examines the Chinese biopharma sector's shift toward a more self-reliant, globally integrated ecosystem, leading early-stage innovation and licensing despite reduced nondomestic VC and rising geopolitical frictions.